These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 9690571

  • 21. Simvastatin in the treatment of asthma: lack of steroid-sparing effect.
    Cowan DC, Cowan JO, Palmay R, Williamson A, Taylor DR.
    Thorax; 2010 Oct; 65(10):891-6. PubMed ID: 20861293
    [Abstract] [Full Text] [Related]

  • 22. A comparison of clinical use of fluticasone propionate and beclomethasone dipropionate in pediatric asthma.
    Nong BR, Huang YF, Hsieh KS, Huang YY, Huang CF, Chuang SL, Liu CC.
    Kaohsiung J Med Sci; 2001 Jun; 17(6):302-11. PubMed ID: 11559968
    [Abstract] [Full Text] [Related]

  • 23. Allergen exposure decreases glucocorticoid receptor binding affinity and steroid responsiveness in atopic asthmatics.
    Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DY.
    Am J Respir Crit Care Med; 1997 Jan; 155(1):87-93. PubMed ID: 9001294
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule.
    Kunkel G, Rydén AC.
    Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma.
    Westbroek J, Saarelainen S, Laher M, O'Brien J, Barnacle H, Efthimiou J.
    Respir Med; 1999 Oct; 93(10):689-99. PubMed ID: 10581657
    [Abstract] [Full Text] [Related]

  • 29. [Effect of FP inhalation and airway inflammation assessed by ECP in asthma].
    Haneda H, Koizumi M.
    Nihon Kokyuki Gakkai Zasshi; 2001 Jun; 39(6):394-8. PubMed ID: 11530386
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Difficult-to-control asthma: clinical characteristics of steroid-insensitive asthma.
    Chan MT, Leung DY, Szefler SJ, Spahn JD.
    J Allergy Clin Immunol; 1998 May; 101(5):594-601. PubMed ID: 9600494
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Eosinophil and mast cell parameters in children with stable moderate asthma.
    Hoekstra MO, Grol MH, Hovenga H, Bouman K, Stijnen T, Koëter GH, Gerritsen J, Kauffman HF.
    Pediatr Allergy Immunol; 1998 Aug; 9(3):143-9. PubMed ID: 9814729
    [Abstract] [Full Text] [Related]

  • 37. Fifty microg b.i.d. of inhaled fluticasone propionate (FP) are effective in stable asthmatics previously treated with a higher dose of FP.
    Giannini D, Di Franco A, Tonelli M, Bartoli ML, Carnevali S, Cianchetti S, Bacci E, Dente FL, Vagaggini B, Paggiaro PL.
    Respir Med; 2003 May; 97(5):463-7. PubMed ID: 12735661
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. In vivo modulation of glucocorticoid receptor mRNA by inhaled fluticasone propionate in bronchial mucosa and blood lymphocytes in subjects with mild asthma.
    Andersson O, Cassel TN, Grönneberg R, Brönnegård M, Stierna P, Nord M.
    J Allergy Clin Immunol; 1999 Apr; 103(4):595-600. PubMed ID: 10200007
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.